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Bone resorption by macrophage polykaryons of giant cell tumour of
tendon sheath
N.A. Athanasou, J. Quinn, D.J.P. Ferguson & J.O'D. McGee
Nuffield Department ofPathology, John Radeliffe Hospital, Headington, Oxford OX3 9DU, UK.
Summary The antigenic phenotype, ultrastructure and bone resorbing ability of mononuclear and multi-
nucleated giant cells of four giant cell tumour of tendon sheath (GCTTS) lesions was assessed. Both the giant
cells and the mononuclear cells exhibted the antigenic phenotype of cells of the monocyte/macrophage lineage.
The giant cells, unlike osteoclasts, did not respond morphologically to calcitonin and showed ultrastructural
and immunophenotypic features of macrophage polykaryons. However, like osteoclasts, the giant cells showed
direct evidence of resorption pit formation on bone slices. This indicates that the GCTTS is composed of cells
of histiocytic differentiation with the giant and mononuclear cell components expressing a similar antigenic
phenotype. Bone resorption by macrophage polykaryons shows that this is not a unique defining characteristic
of osteoclasts. Qualitative differences in the degree and pattern of bone resorption by macrophage polykaryons
distinguish it from that of osteoclasts and may underlie the clinical behaviour of osteolytic lesions.
Giant cell tumour of tendon sheath (GCTTS) is a benign
lesion composed of cellular fibrous tissue in which there are
numerous mononuclear histiocyte-like cells and multinu-
cleated giant cells (Enzinger & Weiss, 1983). Foamy macro-
phages and hemosiderin, some of which is present in
macrophages, are also present. The origin and nature of the
cell types found in GCTTS is unclear. Ultrastructural studies
have shown similarities between some of the mononuclear
cells in GCTTS and Type A (histiocyte-like) and Type B
(fibroblast-like) synovial lining cells with the giant cells
apparently derived from fusion of the Type A synovial lining
cells (Alguacil-Garcia et al., 1978; Eisenstein, 1968). Other
studies have suggested that the mononuclear cell component
resembles osteoblasts and the giant cell component, osteo-
clasts (Carstens, 1978). Recent immunohistochemical studies
have also suggested that the giant cells are osteoclasts and
that cells in the lesion show true histiocytic differentiation
(Wood et al., 1988), and do not support the concept that the
lesion is a form of xanthoma or benign fibrous histiocytoma
(Rosai, 1981).
There have been several recent studies on the nature of
giant cells in giant cell lesions of bone and soft tissue which
have used bone resorption as an operational or functional
criterion to determine whether tumour-associated giant cells
present in a pathological lesion are osteoclasts (Athanasou et
al., 1983; Flanagan & Chambers, 1988; Flanagan & Cham-
bers, 1989). In this way, giant cells derived from a giant cell
reparative granuloma of the jaw (Flanagan & Chambers,
1988) and giant cells from a giant cell rich malignant fibrous
histiocytoma (Flanagan & Chambers, 1989) were considered
to be osteoclasts. However, it has recently been shown that
tumour-associated macrophage polykaryons derived from a
primary breast carcinoma are also able to resorb bone
(Athanasou et al., 1989). This result appeared inconsistent
with the general belief that no polykaron other than an
osteoclast is capable of bone resorption (Chambers & Hor-
ton, 1984).
In this study, we have analysed the nature of both the
mononuclear and multinucleated cells in GCTTS. We have
determined whether giant cells derived from this tumour are
capable of bone resorption and have analysed the antigenic
phenotype and ultrastructure of the two components. The
results have implications for current theories of osteoclast
ontogeny and definition as well as for aspects of tumour-
associated osteolysis.
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Materials and methods
Bovine parathyroid hormone (PTH) (2,500 U mg ')was pro-
vided by Dr J. Zanelli (National Institute for Biological
Standards, London, UK) and dissolved (230 IU ml-') in 1 ml
0.001% acetic acid in distilled water containing 1 mgml1' of
bovine serum albumin (Sigma, UK) (BSA). Salmon calcito-
nin (CT) was donated by Armour Pharmaceuticals, East-
bourne, UK (4,450 IU mg-1) and dissolved (1 mgml') in
0.05% NaCl and 0.2% sodium acetate in distilled water
containing 1 mgml-' of BSA. Prostaglandin E2 (Sigma)
(PGE2) was dissolved (10-2 M) in alcohol. 1,25-Dihydroxy
vitamin D3 [1,25-(OH2D3] was donated by Roche products
(Welwyn Garden City, UK) and dissolved (10-2 M) in alco-
hol. Interleukin-1 (IL-1) was kindly provided by Dr J. Sak-
latvala and dissolved (200 ngml-') in RPMI.
Four GCTTS lesions were examined. These were from the
left index finger of a 37 year old female, the right index finger
of a 58 year old male and the right and left middle fingers of
a 45 year old male. In all cases, part of the lesion was fixed
in formalin and processed routinely. For transmission elec-
tron microscopy, tiny samples of tissue were fixed in 4%
phosphate buffered glutaraldehyde for 6 h, then post-fixed_in
2% buffered osmium tetroxide for 2 h. Tissue was dehydrat-
ed in graded alcohol, treated with propylene oxide and
embedded in epoxy resin (EMix). Thin sections were stained
with uranyl acetate and lead citrate, and examined in a Jeol
100 CX electron microscope. Samples of the tumour were
also snap-frozen in liquid nitrogen and then stored at -220C
for cytostate sectioning. Several antigenic determinants were
sought in cryostat sections of the lesions after the application
of monoclonal antibodies listed in Table I. These antibodies
were derived from the Third and Fourth Workshops on
Human Leucocyte Differentiation Antigens (Hogg & Horton,
1987; Knapp et al., 1989). Immunohistochemistry was per-
formed using an indirect immunoperoxidase technique (Gat-
ter et al., 1984).
Preparation ofisolated macrophages andmacrophage
polykaryons
The remainder of the tissue was placed in normal saline and
then transferred to Hanks BSS (Gibco). The tumour was cut
into small pieces, digested for 2 h in Hanks containing 10
mgml-' collagenase type II (Sigma). The solution was then
centrifuged and the resulting cell pellet dissolved in 5 ml of
RPMI 1640 (Gibco) containing 10% foetal calf serum
(RPMI/FCS). Phase contrast examination of this suspension
revealed large numbers of multinucleated cells interspersed
amongst abundant mononuclear cells.
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Table I Results of immunohistochemical staining of sections of giant cell tumour of tendon sheath
Reactivity of
Reactivity of mononuclear
Antibody Specificity Sourcea giant cells macrophages
iCiI CDlla (LFA-1) Kornbluth + + + +
MHM23 CD lla (LFA-1) McMichael + + + +
5A4.C5 CDl lb (CR3 a chain) Ashmann + + + +
MN41 CD lb (CR3 a chain) Buyon + + + +
TMG6-5 CDllb (CR3 at chain) Ando + + + +
L29 CDlIc (p150,95 a chain) Lanier + +
B-LY6 CDlIc (p150,95 a chain) Poppema + +
UCHM1 CD14 Beverley + +
ClB-Mon/l CD14 Tetteroo + +
VEP13 CD16 (FcRIII) Rumpold + +
MY23 CD16 (FcRIII) Civin + +
CLB-HEC/75 CD31 Von dem Borne + +
2E1 CD32 (FcRII) Tursz + +
CIKM3 CD32 (FcRII) Pilkington + +
BMAC1 CD45 (Leucocyte common Dalchau + +
antigen)
BMAC3 CD45 (Leucocyte common Dalchau + +
antigen)
10.1 CD64 (FcRI) Hogg + +
EBM/I1 CD68 (Macrophage-associated McGee + + + +
antigen)
+ - weak staining; + + - strong stainnig. aSee Knapp et al. (1989).
Response to calcitonin
The cell suspension was added to the wells of a 16 mm
diameter Costar plate containing 15 mm glass coverslips;
these were incubated for 30 min at 37°C in 5% CO2. The
coverslips were then removed from these wells and washed
vigorously to remove non-adherent cells. One of a pair of
coverslips was then placed in a well containing CT (1 pg
ml-'), the other in control tissue culture medium. The cells
were observed by phase contrast microscopy for 1 h to deter-
mine if their was any morphological response to calcitonin
(Chambers & Magnus, 1982), after which they were fixed in
formalin for Giemsa staining. This procedure was repeated
with cells incubated on coverslips overnight in RPMI/FCS.
Cell culture on bone slices
The cell suspension was added to the wells (16 mm diameter)
of a tissue culture plate (Costar, UK) containing four cortical
bone slices prepared as previously described (Chambers et al.,
1984), or to 15 mm glass coverslips. The cell suspension was
incubated on these for 60 min at 37°C. The bone slices and
the coverslips were then removed, washed vigorously in
MEM and placed in fresh 16 mm diameter wells (two bones
per well). For the bone slices, these contained one of the
following: PTH (10 IU ml-'), PGE2 (10- M), CT (1 g
ml-'), 1.25 (OH)2D3 (10-` M), interleukin-l (IL-1) (10 ng
ml-') or appropriate vehicle controls in 1 ml of RPMI/FCS.
These were incubated for periods of 3 and 7 days. Two bone
slices from each of these cultures was fixed in 4% gluta-
raldehyde in 0.2 M cacodylate buffer for 2 h. The other two
bone slices were placed in Triton X-100 (0.1% in distilled
water) for 6 h before glutaraldehyde fixation. This treatment
removes all cells from the bone surface and allows the under-
lying substrate to be examined for evidence of bone resorp-
tion. The specimens were dehydrated through a graded
ethanol series and critical point dried from CO2. Specimen
were sputter coated with gold and examined in a Philips
SEM 505 scanning electron microscope.
The number of giant cells on the bone slices and the
number of resorption pits on the corresponding Triton-
treated bone slices which had shared the same well were
counted in cultures incubated for 3 days and 7 days. The
surface area of each resorption pit was calculated by tracing
the outline of the pit on to a digitising tablet linked to a
Kontron MOP AMO3 image analyser.
The coverslips containing cell suspension were also incub-
ated in RPMI/FCS for 24 h, 3 days and 7 days in order to
assess the number and nature of the cells after these periods
of incubation. These were fixed in cold acetone and the
histiocytic nature of the cells present on the coverslips con-
firmed by immunohistochemistry with monoclonal antibody
EBM/l (Kelly et al., 1988).
Controls
To confirm the validity of the CT response and the bone
resorption assay, rodent osteoclasts were isolated and cul-
tured as previously described (Chambers et al., 1984). These
showed respectively an inhibitory response to salmon CT and
production of numerous resorption pits on bone slices.
Results
Histopathology
All cases of GCTTS contained abundant multinucleated
giant cells and round, plump or spindle shaped mononuclear
stromal cells with scattered foamy macrophages and hemo-
siderin deposits. No calcified material was seen in any of the
lesions studied.
Ultrastructuralfindings
The ultrastructural appearance of the giant cells was similar
in GCTTS of the three patients examined by TEM. The cells
contained a variable number (2-14) of nuclei with irregular
outlines. The nucleoplasm was relatively homogeneous with
small amounts of peripherally located dense heterochromatin
plus large or single multiple nucleoli (Figure la). The smaller
giant cells (2-4 nuclei) exhibited some variation in shape
ranging from relatively elongated to cuboid in apparance.
The cytoplasm of the giant cells contained numerous small
cigar-shaped mitochondria admixed with strands of rough
endoplasmic reticulum and polyribosomes plus a number of
small vacuoles (Figure lb). Golgi bodies were also present,MACROPHAGES, POLYKARYONS AND BONE RESORPTION 529
Response to calcitonin andmorphology ofcell cultures on
coverslips
Both mononuclear cells and multinucleated giant cells, which
had settled immediately after isolation onto glass coverslips,
rapidly expanded their cytoplasm and were highly motile.
The giant cells had an abundant, well spread, pale staining
cytoplasm which in some cells appeared vacuolated. They
had a smooth outline and often extended broad pseudopods.
Unlike osteoclasts, which become immotile and retract cyto-
plasmic pseudopods almost immediately after exposure to
calcitonin, the giants cells remained motile and retained their
broad cytoplasmic outlines. Mononuclear cells were of two
types; one spindle shaped, the other a round or ovoid cell
with one or more small or large pseudopodal extensions.
Motile, mononuclear cells were also noted and these showed
no response to calcitonin treatment.
The morphological appearance of the mononuclear and
multinucleated cells did not change after incubation for 24 h,
3 and 7 days, although the number of round and spindle
shaped mononuclear cells increased. Most of the round and
spindle shaped mononuclear cells as well as the multinucleat-
ed cells reacted with EBM/11 for the CD68 macrophage-
associated antigen.
Cell culture on bone slices and bone resorption by GCTTS cells
Multinucleated cells were easily distinguished from scattered
small mononuclear cells by their large size (up to 100 mi-
crons) and complex surface specialisations; these included
scattered fine microvilli and numerous ruffles over their free
(upper) surface and pseudopodal extensions. At the edge of
the cell body, there were numerous filopodia or retraction
fibres which anchored the cell to the bone surface. Several
large multinucleated cells were flattened against the bone
surface and had few surface specialisations.
Figure 1 Low power transmission electron micrograph showing
the in situ appearance of a multinucleate giant cell within the
tumour. Bar is 10ltm. b, detail of the giant cell cytoplasm
showing the Golgi bodies, numerous mitochondria, strands of
rough endoplasmic reticulum and free ribosomes. Note the finger-
like projections of the plasmalemma and the narrow underlying
organelle free zone. Bar is 1 iLm.
predominantly adjacent to the nuclei (Figure lb). Around the
periphery of the cells was a narrow (120 nm wide) organelle
free zone consisting of fine filaments. The plasmalemma was
relatively smooth although certain areas exhibited numerous
finger-like or bulbous projection (Figure lb).
In certain cases, the giant cells were surrounded by col-
lagen filaments while others were admixed with 'mono-
nuclear' cells (Figure la). In these latter examples, many of
the 'mononuclear' cells had a similar nuclear and cytoplasmic
morphology to those of the giant cells (Figure la).
Immunohistochemistry
Both mononuclear cells and multinucleated giant cells ex-
pressed numerous leucocyte and macrophage-associated anti-
gens including CD45 (leucocyte common antigen - LCA),
CD13, CD14, and CD68 (macrophage-associated antigens)
(Table I) (Figure 2). They also expressed all the leucocyte
integrin antigens, CD1 la (LFA-1), CD1 lb (CR3), CD1 lc
(p150,95) and CD18 (Figure 2). The giant cells expressed
HLA-DR, transferrin receptor (CD71) and receptors for
complement (CD1ib, CD35) and Fc components (CD16,
CD32, CD64) of immunoglobulin (Figure 2). The plump and
spindle shaped mononuclear cells showed expression of a
similar range of antigens. Both mononuclear and multi-
nucleated cells also expressed CD51 and CD61, the alpha
and beta chains respectively of the vitronectin receptor.
Figure 2 Indirect immunoperoxidase staining of both mono-
nuclear and multinucleated giant cells of a GCTTS with mono-
clonal antibodies: a, EBM/11 anti-CD68 (macrophage-associated
antigen). Strong staining of the cytoplasm of the giant cells
(arrowed) x 400. b, TMG6-5, antibody to CDIlb (CR3) x 600.530 N.A. ATHANASOU et al.
The small mononuclear cells were either spindle shaped or
rounded and contained numerous ruffles and microvilli over
the cell body. These frequently contained fine and broad
pseudopodal extensions.
Bone resorption by GCTTS cells
In all cell cultures on bone slices, there was evidence of bone
resorption associated with large presumed multinucleated
cells (Figure 3a). This was essentially of two types. The first
closely resembled osteoclast resorption pits and included cir-
cular, serpiginous and compound excavations (Figures 3b
and 3c). Although a few large resorption areas were seen, the
majority (>95%) of pits were less than 500gm2; this size is
generally smaller than resorption pits associated with rodent
and giant cell tumour of bone-derived osteoclasts. In addi-
tion, very few pits were formed given the number of giant
cells present on the bone slices (Table II). Secondly, assoc-
iated with both small mononuclear and large multinucleated
cells were poorly defined areas of discernible surface rough-
ening or resorption (Figure 4). These areas of surface altera-
tion contrasted with the surrounding smooth bone surface by
containing exposed mineralised collagen fibres. The areas
were generally concentrated around large cells, which often
formed cell clusters. They were also seen in the vicinity of
resorption pits and in some cases merged with the edges of
an otherwise well-defined resorption pit.
Osteotropic hormones had no significant effect on bone
resorption (Table II).
Discussion
The immunohistochemical findings show that GCTTS is
composed of cells of histiocyte differentiation. The giant cells
express a similar antigenic phenotype to that of mononuclear
cells and would appear to form by fusion of these cells. The
histocytic nature of the mononuclear cells would appear to
distinguish them from both osteoblasts and mononuclear
cells of fibrohistocytic lesions (Wood et al., 1986). However,
the possibility that these cells are ofsynovial origin cannot be
excluded as cells of the monocyte/macrophage lineage are
found within or lining synovial tissue (Edwards, 1982;
Athanasou et al., 1988). Synovial lining cells have an antigen
phenotype which closely resembles that of tissue macro-
phages being characterised by weak or low frequency expres-
sion of CD Ila and also CDlIc (Hale et al., 1989; Allen et
al., 1989), features not noted in the cases studied.
The giant cells of GCTTS expressed a wide range of
monocyte/macrophage-associated antigens including CD14
and the leucocyte integrins CD1la,b,c and CD18 (LFA
family). They also expressed receptors for Fc and comple-
ment components as well as HLA-DR. The osteoclast anti-
genic phenotype is characterised by absence of these antigens
and expression of a highly restricted range of macrophage-
associated antigens (Athanasou & Quinn, 1990). The giant
cell antigenic phenotype resembled that of tissue macro-
phages, a feature characteristic of macrophage polykaryons
(Athanasou & Quinn, 1990). Consistent with this, we found
that the immunohistochemical staining pattern of most
mononuclear and multinucleated cells in the GCTTS was
identical. This extended to expression of CD51 (a chain of
the vitronectin receptor), an antigen that was formerly
thought to be osteoclast-specific (Horton et al., 1985) but is
now known to be present on a variety of cell types including
foreign body macrophage polykaryons (Athanasou et al.,
1990).
In a previous enzyme histochemical and immunohisto-
chemical study of GCTTS, the giant cells were considered to
resemble osteoclasts largely on the basis of enzyme activity
for acid phosphatase, ATP'ase, beta glucuronidase, alpha
naphthyl acetate esterase and 5' nucleotidase; macrophages
and sinus histiocytes contained more naphthyl acetate ester-
ase and less acid phosphatase than osteoclasts (Wood et al.,
1988). None of these enzymes are specific for monocytes,
Figure 3 Scanning electron micrographs of bone slices on which
cells from giant cell tumour of tendon sheath have been cultured.
These show: a, a giant cell and a smaller macrophage (bar is
10gm). b, a group of resorption pits, including a large multiple
pit (triton treated bone slice: bar is 10#Lm). c, detail of a resorp-
tion pit (triton treated bone slice: bar is 5tm).MACROPHAGES, POLYKARYONS AND BONE RESORPTION 531
Table II Mean number of resorption pits per bone slice and mean
surface area of resorption pits
Mean surface
Mean no of Mean no of area of
macrophage resorption pits resorption
polykaryons ( s.e.m.) (±s.e.m. (ilm2)
3 day culture
Control 46 4.25± 1.38 998.5± 377.74
PTH 49 3.25± 1.65 365.0±229
1,25 (OH2)D3 38 5.25±2.84 853.0±496
PgE2 37 0 0
IL-la 52 1 289
Calcitonin 48 1 68
7 day culture
Control 22 8.50±6.85 1009±705
PTH 16 8.00± 3.72 5473±4974
1,25 (OH2)D3 18 10.00±2.86 2009±824
PgE2 14 3.00±3.00 1569± 1569
IL-la 17 2.50±2.50 381±381
Calcitonin 19 2.00±2.00 187± 381
macrophages, their fused products or osteoclasts (Gothlin &
Ericsson, 1976; Papadimitriou & Walters, 1989). Wood et al.
(1988) also found that GCTTS giant cells expressed leucocyte
common antigen and several macrophage markers including
HLA-DR and CD14, antigens which are not present on
osteoclasts. However, expression of these antigens (confirmed
in the present study) is characteristic of macrophage poly-
karyons (Athanasou & Quinn, 1990). As in the present study,
mononuclear cells and giant cells expressed a similar antigen
phenotype. Confirmation that the giant cells of GCTTS are
macrophage polykaryons is seen in their lack of morpho-
logical response to CT (Chambers & Magnus, 1982) and
their ultrastructural features which show no evidence of
ruffled border formation although the latter is only seen
adjacent to a bone substrate (Gothlin & Ericsson, 1976). The
numerous polyribosomes and rER cisternae and the fine
filament bundles in the subplasmalemmal zone noted in this
and previous studies (Alguacil-Garcia et al., 1978) are also
consistent with the giant cells of the lesion studied being
designated macrophage polykaryons (Papadimitriou &
Walters, 1979). Murrills et al. (1989) noted that human
osteoclasts showed a variable, occasionally absent response
to CT; they used human CT which is less potent than the
salmon CT used in this and other studies which have shown
a CT effect on human osteoclasts and osteoclast-like giant
cells (Chambers et al., 1985; Athanasou et al., 1986).
One of the features which the giant cells exhibited was the
ability to produce characteristic resorption pits on bone
slices. There have been several in vitro studies which provide
indirect evidence that mononuclear phagocytes can degrade
both the mineral and organic components of bone (Teitel-
baum et al., 1979; Mundy et al., 1977; Fallon et al., 1983).
However, rodent macrophage polykaryons have been shown
to lack the ability to produce resorption pits (Chambers &
Horton, 1984), a property which both rodent and human
osteoclasts possess (Athanasou et al., 1983; Chambers et al.,
1984; Murrills et al., 1989). Consequently, the ability to
produce resorption pits is now employed as an operational or
defining characteristic of a cell as an osteoclast (Chambers,
1985; Horton, 1988).
Direct evidence of bone resorption in conjunction with a
positive immunohistochemical reaction with anti-CD51 anti-
bodies has been used to categorise giant cells from two giant
cell lesions as osteoclasts (Flanagan & Chambers, 1988;
Flanagan & Chambers, 1989). However, it is now clear that
anti-CD51 antibodies are not osteoclast-specific and that they
also stain macrophage polykaryons (Athanasou et al., 1990).
It has also recently been shown that macrophage poly-
karyons isolated from a breast carcinoma are capable of
osteoclast-like bone resorption (Athanasou et al., 1989).
These polykaryons, like those from the GCTTS, did not
Figure 4 Scanning electron micrographs showing surface rough-
ening by cells cultured from giant cell tumour of tendon sheath.
a, giant cell with associated area of surface roughening. b, inter-
face between area of surface roughening edge of resorption pit
and cell, which appears to partly overly a resorption pit. (Bar is
10gm). c, relatively well defined area of surface roughening
(Triton-treated bone slice). (Bar is 10gm).
response to calcitonin and showed phenotypic and ultrastruc-
tural differences from osteoclasts. The degree and pattern of
bone resorption by the polykaryons in both giant cell lesions
also shows some similarities.
Although numerous GCTTS-derived giant cells were pre-
sent on the bone slices, relatively few resorption pits being
produced by these cells, even after incubation for several
days. This pattern of bone resorption is completely different
from that of rodent osteoclasts (Chambers et al., 1984) or the532 N.A. ATHANASOU et al.
osteoclast-like giant cells of a giant cell tumour of bone
(Chambers et al., 1985), both of which produce numerous
resorption pits on bone slices. Moreover, although a few
large resorption areas were seen, the resorption pits produced
by GCTTS and tumour-associated giant cells were generally
smaller than those associated with osteoclasts as well as fewer
in number (Flanagan & Chambers, 1988; Flanagan & Cham-
bers, 1989; Athanasou et al., 1989). In addition, cells isolated
from the GCTTS produced poorly defined areas of surface
roughening, a type of bone degradation which has previously
been noted to be an uncommon form of osteoclastic bone
resorption (Chambers et al., 1984).
Recognition that macrophage polykaryons are capable of
bone resorption is important for several reasons. First, it
indicates that direct evidence of bone resorption is not in
itself sufficient to define a polykaryon as an osteoclast.
Secondly, it supports earlier studies which have indirectly
shown that monocytes, macrophages and macrophage poly-
karyons are capable of bone degradation (Teitelbaum et al.,
1979; Mundy et al., 1977; Fallon et al., 1983). It also estab-
lishes another phenotypic similarity between these cells and
the osteoclast. Recently, mononuclear and multinucleated
cells, generated by long-term culture of bone marrow cells,
have shown a limited ability to resorb bone (Kukita et al.,
1989). It has been suggested that such cells may represent
mononuclear osteoclast precursors and osteoclasts respec-
tively. However, the possibility that such bone-resorbing
multinucleated cells are macrophage polykaryons rather than
osteoclasts should also be considered.
Finally, the fact that bone resorption by macrophage poly-
karyons is characterised by fewer and smaller resorption pits
than that of osteoclast-containing lesions indicates that there
are differences in the pattern of polykaryon-associated osteo-
lysis. This could account for differences in the clinical
behaviour of osteolytic lesions such as tumour size, rate of
growth or aggressiveness. This may be of significance with
respect to the behaviour of the many different giant cell
lesions of bone and soft tissue that are clinically associated
with varying degrees of osteolysis, some of which has been
shown to be due to giant cells (Rosai, 1981; Athanasou et al.,
1983; Flanagan & Chambers, 1988; Flanagan & Chambers,
1989). It could also conceivably influence the behaviour of
osteolytic bony metastases where different pattern of osteo-
clast/giant cell bone resorption have been noted (Galasko,
1982).
We thank Miss L. Watts for preparing the manuscript. NAA is an
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